Tenet Healthcare (THC) Tops Q2 EPS by $1.97

Go back to Tenet Healthcare (THC) Tops Q2 EPS by $1.97

Tenet Reports Results for the Second Quarter Ended June 30, 2020 and Provides Update on Effects of COVID-19

August 3, 2020 4:15 PM EDT

Net income from continuing operations available to common shareholders of $88 million, or $0.83 per diluted share, in 2Q20 versus net income from continuing operations of $24 million, or $0.23 per diluted share, in 2Q19 Consolidated Adjusted EBITDA of $732 million in 2Q20 versus $669 million in 2Q19 Federal stimulus support received was critical in addressing pandemic challenges, allowing uninterrupted response across our care facilities Experienced pronounced volatility in monthly volumes associated with COVID-19 during 2Q20, including restrictions on elective procedures, with April lows followed by substantial improvement in May and... More